These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24496437)

  • 1. Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision.
    Denise H; Moschos SA; Sidders B; Burden F; Perkins H; Carter N; Stroud T; Kennedy M; Fancy SA; Lapthorn C; Lavender H; Kinloch R; Suhy D; Corbau R
    Mol Ther Nucleic Acids; 2014 Feb; 3(2):e145. PubMed ID: 24496437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
    Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
    Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
    RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.
    Theotokis PI; Usher L; Kortschak CK; Schwalbe E; Moschos SA
    Mol Ther Nucleic Acids; 2017 Dec; 9():22-33. PubMed ID: 29246301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Dicer enhances RNAi-mediated gene silencing by short-hairpin RNAs (shRNAs) in human cells.
    Mikuma T; Kawasaki H; Yamamoto Y; Taira K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):191-2. PubMed ID: 17150543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.
    Lisowski L; Elazar M; Chu K; Glenn JS; Kay MA
    Nucleic Acids Res; 2013 Apr; 41(6):3688-98. PubMed ID: 23396439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA.
    Machitani M; Sakurai F; Wakabayashi K; Takayama K; Tachibana M; Mizuguchi H
    Mol Ther Nucleic Acids; 2017 Mar; 6():173-182. PubMed ID: 28325284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Mockenhaupt S; Grosse S; Rupp D; Bartenschlager R; Grimm D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4007-16. PubMed ID: 26170322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of stable 3'-mRNA cleavage fragments induced by siRNA in cells with high-levels of duck hepatitis B virus replication.
    Lan L; Mao Q; Blum HE
    Biochem Biophys Res Commun; 2014 Jan; 443(3):834-9. PubMed ID: 24342609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids.
    Lima WF; Murray H; Nichols JG; Wu H; Sun H; Prakash TP; Berdeja AR; Gaus HJ; Crooke ST
    J Biol Chem; 2009 Jan; 284(4):2535-48. PubMed ID: 19017633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.
    Khaliq S; Jahan S; Ijaz B; Ahmad W; Asad S; Pervaiz A; Samreen B; Khan M; Hassan S
    Virol J; 2010 Nov; 7():318. PubMed ID: 21073745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of extended short hairpin RNAs for HIV-1 inhibition.
    Liu YP; Haasnoot J; Berkhout B
    Nucleic Acids Res; 2007; 35(17):5683-93. PubMed ID: 17715143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy profile and secondary structure impact shRNA efficacy.
    Zhou H; Zeng X
    BMC Genomics; 2009 Jul; 10 Suppl 1(Suppl 1):S9. PubMed ID: 19594886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA.
    Jin X; Sun T; Zhao C; Zheng Y; Zhang Y; Cai W; He Q; Taira K; Zhang L; Zhou D
    Nucleic Acids Res; 2012 Feb; 40(4):1797-806. PubMed ID: 22039150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
    Shan ZX; Lin QX; Yang M; Deng CY; Kuang SJ; Zhou ZL; Xiao DZ; Liu XY; Lin SG; Yu XY
    Mol Cell Biochem; 2009 Mar; 323(1-2):81-9. PubMed ID: 19037714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
    Rao DD; Maples PB; Senzer N; Kumar P; Wang Z; Pappen BO; Yu Y; Haddock C; Jay C; Phadke AP; Chen S; Kuhn J; Dylewski D; Scott S; Monsma D; Webb C; Tong A; Shanahan D; Nemunaitis J
    Cancer Gene Ther; 2010 Nov; 17(11):780-91. PubMed ID: 20596090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
    Vlassov AV; Korba B; Farrar K; Mukerjee S; Seyhan AA; Ilves H; Kaspar RL; Leake D; Kazakov SA; Johnston BH
    Oligonucleotides; 2007; 17(2):223-36. PubMed ID: 17638526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA.
    Galka-Marciniak P; Olejniczak M; Starega-Roslan J; Szczesniak MW; Makalowska I; Krzyzosiak WJ
    Biochim Biophys Acta; 2016 Apr; 1859(4):639-49. PubMed ID: 26921501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.